STING1 and cancer: The research on STING agonists mainly centered around “cancer immunotherapy.” In addition, “adjuvant,” “innate immunity,” “nanoparticles,” “inflammation,” “apoptosis,” “immune checkpoint blockade,” and other aspects are also active research topics related to STING agonists in recent years.